In late June, a few days before Disability Pride Month began, I took my 7-year-old child on an outing to an Ikea store. As I ...

The study will assess the efficacy and safety of zorevunersen compared to sham over a 52-week treatment period.

Good morning. As AI becomes more widely used in health care, could it actually lead doctors to lose some of their skills? One ...

The global Phase III EMPEROR trial (NCT06872125) will evaluate the safety and efficacy of zorevunersen, a novel antisense ...

Stoke Therapeutics and Biogen have begun dosing in the global Phase III EMPEROR study of zorevunersen for Dravet syndrome, ...

Stoke Therapeutics Inc (STOK) reports promising advancements in its Dravet syndrome program and strategic partnerships, ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

Dravet syndrome is a type of epilepsy that starts during a child's first year. If your child has this condition, they might have seizures that last for several minutes at a time.

Isabelle Whitehead, a student at Ripon Grammar School, has earned a place to study medicine, inspired by the care given to ...

People with Dravet syndrome experience intractable seizures throughout their lives — seizures that usually begin before they are 1 year old. What’s more, these seizures aren’t all of the ...

The Brennan family will host the 7th Annual Dance for Dravet on September 26th at the Third Degree Glass Factory to raise ...